Scientists can now search, understand and act on complex R&D data in natural language by leveraging leading LLM capabilities within the Signals One platform Governed data and ontology-driven scientific context support reliable, traceable results across workflows Native agentic framework turns connected data and knowledge into task-ready insights for scientists WALTHAM, Mass. — Revvity, Inc. (NYSE: RVTY) […]
Stockholders to Receive $18.50 Per Share in Cash Representing a 26% Premium to 60-day Volume-Weighted Average Price Transaction to Strengthen Simulations Plus and Accelerate Growth Through Anticipated Combination with Chemical Computing Group RESEARCH TRIANGLE PARK, N.C. — Simulations Plus, Inc. (Nasdaq: SLP) (“Simulations Plus” or the “Company”), a global leader in model-informed and AI-accelerated drug […]
Founded by the team who created the field of generative genomics, Radical Numerics’ Seed funding will accelerate its mission to advance biological design for human health and build the biodefenses to protect it. SAN FRANCISCO — Radical Numerics, an AI research lab building general biological intelligence, today announced its launch with $50 million in seed […]
Ross Muken to assume the role of Chief Executive Officer effective July 1, 2026; Co-founder Dr. Jurgi Camblong nominated for election as Chairman of the Board BOSTON and ROLLE, Switzerland — SOPHiA GENETICS (Nasdaq: SOPH), a global leader in Ai-driven precision medicine, today confirmed, ahead of its 2026 Annual General Meeting (AGM) scheduled for June 18, 2026, […]
SOPHiA GENETICS and Memorial Sloan Kettering Cancer Center Aim to Establish Precision Medicine Hub for the Next Generation of Precision Oncology NEW YORK — SOPHiA GENETICS (NASDAQ: SOPH) today announced that the company has signed a Memorandum of Understanding (MOU) with Memorial Sloan Kettering Cancer Center (MSK) relating to the formation of a joint venture between the two […]
New conversational AI platform leverages the world’s largest human genetics database to power target discovery and validation. Mystra AI is the market-leading agent, accessible to all scientists in Research & Development and Business Development & Licensing. 95% of drug candidates in clinical trials fail. Targets with human genetic support are 2.6 times more likely to […]
New conversational AI platform leverages the world’s largest human genetics database to power target discovery and validation. Mystra AI is the market-leading agent, accessible to all scientists in Research & Development and Business Development & Licensing. 95% of drug candidates in clinical trials fail. Targets with human genetic support are 2.6 times more likely to […]
Collaboration integrates NVIDIA accelerated computing and the NVIDIA BioNeMo platform with QIAGEN Digital Insights’ curated biomedical knowledge bases Goal to advance how disease mechanisms, therapeutic targets and biomarkers are identified Graph-based AI approach designed to help researchers explore mechanisms, therapeutic targets and biomarkers with greater speed, context and confidence Initial pilot programs available to select […]
OmicsHQ brings together comprehensive, expertly curated, standardized multi-omics datasets from across the scientific ecosystem, complete with pre-processed datasets ready to accelerate research, drug-discovery, and AI-driven innovation. SAN DIEGO — Today Rancho BioSciences, the premier tech-enabled data science partner for biopharma, announced the launch of OmicsHQTM, a unified catalog of expertly curated, standardized multi-omics datasets designed for immediate […]
17-Year Multiomics Pioneer Powers Next Era of Precision Health MOUNTAIN VIEW, Calif. — Today, DNAnexus signals a bold new chapter in AI-powered precision health with several new product innovations and solution packages that extend its position as the purpose-built platform where the world’s most scientifically complex data becomes the world’s most powerful AI fuel. These […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
